All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.
For every treatment team and researcher to have instant access to expert opinions and the latest evidence-based information in AML, to aid in treatment decisions and improve the lives of patients globally.
The AML Hub is the solution for a time-stretched HCP to easily access impactful information that expedites learning and empowers their treatment decisions. Informed by patients, curated by world leaders and endorsed by expert societies the AML Hub supports HCPs worldwide.
The AML Hub was founded in partnership with the European Lymphoma Institute (ELI) in 2014. ELI is comprised of a network of top European specialists in the field of lymphoma who are dedicated to research, training, and education. Together they look to define strategies to analyze and characterize lymphoma, common diagnostic procedures, and therapeutic standards, as well as to facilitate clinical and fundamental research. This leads to the advancement of lymphoma research, and works to guarantee equal access for all patients to the best possible care.
The AML Hub is brought to you by Scientific Education Support (SES). SES loves nothing more than building communities and networks to facilitate education through collaboration, ensuring that patients have access to the latest support and treatment options. The SES team takes care of the everyday management, content generation, and uploads onto the AML Hub, assisting the steering committees in keeping the site as up-to-date as possible.